A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy

被引:6
|
作者
Li, Minying [1 ]
Zhang, Jingjing [1 ]
Zha, Yawen [1 ]
Li, Yani [1 ]
Hu, Bingshuang [1 ]
Zheng, Siming [1 ]
Zhou, Jiaxiong [1 ]
机构
[1] Zhongshan City Peoples Hosp, Dept Oncol Radiotherapy, 2 Sunwen Middle Rd, Zhongshan 528403, Guangdong, Peoples R China
关键词
Xerostomia; Nasopharyngeal carcinoma; Prediction; INTENSITY-MODULATED RADIOTHERAPY; QUALITY-OF-LIFE; NECK-CANCER-PATIENTS; RADIATION-THERAPY; HEAD; OUTCOMES; SALIVA; CHEMORADIATION; TOXICITY; PATTERNS;
D O I
10.1186/s12903-022-02269-0
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background This study was to evaluate the predictors of xerostomia and Grade 3 xerostomia in locoregionally advanced nasopharyngeal carcinoma (NPC) patients receiving radical radiotherapy and establish prediction models for xerostomia and Grade 3 xerostomia based on the predictors. Methods Totally, 365 patients with locoregionally advanced NPC who underwent radical radiotherapy were randomly divided into the training set (n = 255) and the testing set (n = 110) at a ratio of 7:3. All variables were included in the least absolute shrinkage and selection operator regression to screen out the potential predictors for xerostomia as well as the Grade 3 xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The random forest (RF), a decision tree classifier (DTC), and extreme-gradient boosting (XGB) models were constructed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), area under the curve (AUC) and accuracy were analyzed to evaluate the predictive performance of the models. Results In the RF model for predicting xerostomia, the sensitivity was 1.000 (95%CI 1.000-1.000), the PPV was 0.990 (95%CI 0.975-1.000), the NPV was 1.000 (95%CI 1.000-1.000), the AUC was 0.999 (95%CI 0.997-1.000) and the accuracy was 0.992 (95%CI 0.981-1.000) in the training set. The sensitivity was 0.933 (95%CI 0.880-0.985), the PPV was 0.933 (95%CI 0.880-0.985), and the AUC was 0.915 (95%CI 0.860-0.970) in the testing set. Hypertension, age, total radiotherapy dose, dose at 50% of the left parotid volume, mean dose to right parotid gland, mean dose to oral cavity, and course of induction chemotherapy were important variables associated with the risk of xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The AUC of DTC model for predicting xerostomia was 0.769 (95%CI 0.666-0.872) in the testing set. The AUC of the XGB model for predicting xerostomia was 0.834 (0.753-0.916) in the testing set. The RF model showed the good predictive ability with the AUC of 0.986 (95%CI 0.972-1.000) in the training set, and 0.766 (95%CI 0.626-0.905) in the testing set for identifying patients who at high risk of Grade 3 xerostomia in those with high risk of xerostomia. Conclusions An RF model for predicting xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy and an RF model for predicting Grade 3 xerostomia in those with high risk of xerostomia showed good predictive ability.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [21] Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
    Ma, J
    Mai, HQ
    Hong, MH
    Min, HQ
    Mao, ZD
    Cui, NJ
    Lu, TX
    Mo, HY
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1350 - 1357
  • [22] An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling
    Zhou, Jiayu
    Deng, Yishu
    Huang, Yingying
    Wang, Zhiyi
    Zhan, Zejiang
    Cao, Xun
    Cai, Zhuochen
    Deng, Ying
    Zhang, Lulu
    Huang, Haoyang
    Li, Chaofeng
    Lv, Xing
    LIFE-BASEL, 2023, 13 (05):
  • [23] Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
    Yao, Ji-Jin
    He, Xiao-Jun
    Lawrence, Wayne R.
    Zhang, Wang-Jian
    Kou, Jia
    Zhang, Fan
    Zhou, Guan-Qun
    Wang, Si-Yang
    Sun, Ying
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (01) : 285 - 292
  • [24] Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models
    Zhang, Xushi
    Zheng, Wanjia
    Huang, Sijuan
    Li, Haojiang
    Bi, Zhisheng
    Yang, Xin
    ORAL ONCOLOGY, 2024, 158
  • [25] Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan, ATC
    Leung, SF
    Ngan, RKC
    Teo, PML
    Lau, WH
    Kwan, WH
    Hui, EP
    Yiu, HY
    Yeo, W
    Cheung, FY
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, TSK
    Yau, S
    Yuen, KT
    Mo, FKF
    Lai, MMP
    Ma, BBY
    Kam, MKM
    Leung, TWT
    Johnson, PJ
    Choi, PHK
    Zee, BCY
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) : 536 - 539
  • [26] Individualized cumulative cisplatin dose for locoregionally-advanced nasopharyngeal carcinoma patients receiving induction chemotherapy and concurrent chemoradiotherapy
    Wen, Dan-Wan
    Li, Zhi-Xuan
    Chen, Fo-Ping
    Lin, Li
    Peng, Bin-ying
    Kou, Jia
    Zheng, Wei-Hong
    Yang, Xing-Li
    Xu, Si-Si
    Sun, Ying
    Zhou, Guan-Qun
    ORAL ONCOLOGY, 2020, 107
  • [28] Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma
    Zibin Liang
    Siyang Wang
    Zhong Lin
    Shaoyan Feng
    Zhibin Cheng
    Yaqi Yang
    Ying Kuang
    Chibhabha Fidelis
    Shahid Ullah
    Feng Li
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 643 - 651
  • [29] Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy
    Cheng, Skye Hongiun
    Jian, James Jer-Min
    Tsai, Stella Y.C.
    Chan, Kwan-Yee
    Yen, Lawrence K.
    Chu, Nei-Min
    Tan, Tran-Der
    Tsou, Mei-Hua
    Huang, Andrew T.
    International Journal of Radiation Oncology, Biology, Physics, 41 (04): : 755 - 762
  • [30] Chemotherapy in locoregionally advanced nasopharyngeal carcinoma-a review
    Krstevska, V.
    Stojkovski, I.
    JOURNAL OF BUON, 2008, 13 (04): : 495 - 503